Global mRNA Vaccines and Therapeutics Market to Reach USD 71.7 Billion by 2034, Growing at 1.20% CAGR

The global mRNA vaccines and therapeutics market was valued at USD 64.5 billion in 2024, driven by the rising incidence of chronic diseases and increasing awareness of the widespread potential of mRNA technology across the globe. Continued advancements in biotechnology, expanding applications beyond infectious diseases, and growing investment in research and development are further supporting market growth. The market is expected to grow at a CAGR of 1.20% during the forecast period of 2025-2034, with values projected to reach USD 71.7 billion by 2034.